We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Horace Mann Educators
HMN
$2.09B
| $328K | ﹤0.01% |
+9,800
| New | +$350K |
|
1327
Tenaya Therapeutics
TNYA
$158M
| $328K | ﹤0.01% |
114,930
| – | – |
|
1328
Pricesmart
PSMT
$6.08B
| $322K | ﹤0.01% |
+4,500
| New | +$315K |
|
|
HUT
1329
Hut 8
HUT
$12.6B
| $320K | ﹤0.01% |
35,226
+6,495
| +23% | +$55.2K |
|
|
NUVL
1330
DELISTED
Nuvalent
NUVL
| $320K | ﹤0.01% |
12,262
| – | – |
|
1331
ePlus
PLUS
$2.45B
| $319K | ﹤0.01% |
6,500
+1,800
| +38% | +$91.3K |
|
|
MPT
1332
Medical Properties Trust
MPT
$2.75B
| $317K | ﹤0.01% |
38,592
-136,090
| -78% | -$1.5M |
|
|
CNTA
1333
DELISTED
Centessa Pharmaceuticals
CNTA
| $316K | ﹤0.01% |
82,055
| – | – |
|
1334
Patterson-UTI
PTEN
$3.9B
| $311K | ﹤0.01% |
26,600
+16,600
| +166% | +$242K |
|
|
ICVX
1335
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $310K | ﹤0.01% |
53,420
+10,000
| +23% | +$86.4K |
|
1336
Patrick Industries
PATK
$2.77B
| $310K | ﹤0.01% |
+6,750
| New | +$313K |
|
1337
Eastern Bankshares
EBC
$5.29B
| $306K | ﹤0.01% |
+24,280
| New | +$374K |
|
|
HLVX
1338
DELISTED
HilleVax
HLVX
| $306K | ﹤0.01% |
18,528
| – | – |
|
1339
Clearfield
CLFD
$436M
| $298K | ﹤0.01% |
6,404
| – | – |
|
1340
Fabrinet
FN
$16.3B
| $297K | ﹤0.01% |
2,500
+900
| +56% | +$112K |
|
1341
Immatics
IMTX
$1.23B
| $296K | ﹤0.01% |
42,900
| – | – |
|
1342
Prime Medicine
PRME
$508M
| $294K | ﹤0.01% |
23,922
| – | – |
|
1343
Invesco DB US Dollar Index Bullish Fund
UUP
$424M
| $285K | ﹤0.01% |
10,233
-14,643
| -59% | -$409K |
|
1344
World Kinect Corp
WKC
$2B
| $281K | ﹤0.01% |
+11,000
| New | +$299K |
|
1345
Arcus Biosciences
RCUS
$3.47B
| $281K | ﹤0.01% |
15,400
-46,900
| -75% | -$896K |
|
1346
iShares China Large-Cap ETF
FXI
$4.35B
| $279K | ﹤0.01% |
9,443
-438
| -4% | -$13.2K |
|
|
COOP
1347
DELISTED
Mr. Cooper
COOP
| $279K | ﹤0.01% |
+6,800
| New | +$298K |
|
1348
Universal Display
OLED
$3.67B
| $277K | ﹤0.01% |
+1,783
| New | +$240K |
|
1349
BJs Wholesale Club
BJ
$12.4B
| $276K | ﹤0.01% |
3,622
+273
| +8% | +$19.8K |
|
1350
RPC Inc
RES
$1.28B
| $275K | ﹤0.01% |
35,800
+19,500
| +120% | +$173K |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.